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Abstract
Background: Integrin linked kinase (ILK), as an important component of mechanical stretch sensor, can initiate cellular
signaling response in the heart when cardiac preload increases. Previous work demonstrated increased ILK expression could
induce angiogenesis to improved heart function after MI. However the patholo-physiological role of ILK in cardiac
remodeling after MI is not clear.
Method and Results: Hearts were induced to cardiac remodeling by infarction and studied in Sprague-Dawley rats. Until 4
weeks after infarction, ILK expression was increased in non-ischemic tissue in parallel with myocytes hypertrophy and
compensatory cardiac function. 8 weeks later, when decompensation of heart function occurred, ILK level returned to
baseline. Followed ILK alternation, vascular endothelial growth factor (VEGF) expression and phosphorylation of endothelial
nitric oxide synthase (eNOS) was significantly decreased 8 weeks after MI. Histology study also showed significantly
microvessel decreased and myocytes loss 8 weeks paralleled with ILK down-regualtion. While ILK expression was maintained
by gene delivery, tissue angiogenesis and cardiac function was preserved during cardiac remodeling.
Conclusion: Temporally up-regulation of ILK level in non-ischemic myocytes by increased external load is associated with
beneficial angiogenesis to maintain infarction-induced cardiac hypertrophy. When ILK expression returns to normal, this
cardiac adaptive response for infarction is weaken. Understanding the ILK related mechanism of cardiac maladaptation
leads to a new strategy for treatment of heart failure after infarction.
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Introduction
Coronary artery disease, especially occlusion of cardiac vessels is
known as the most predominant reason for heart failure. After
infarction, impaired heart contractility induces myocardium
compensatory hypertrophy to attenuate heart dysfunction [1,2,3].
However compensatory hypertrophy after myocardial infarction
(MI) is temporary. In the end, cardiac dilation and myocardium
thinning occurs and heart function is further deteriorated.
Angiogenesis is very important to preserve adapt cardiac
hypertrophy and contractile function. Neo-vascular could support
more oxygen and energy to hypertrophic myocardium in non-
ischemic zone [4,5]. When oxygen and energy support is
insufficient for hypertrophical myocytes, apoptosis or/and necrosis
of cell would occur, leading to myocardium thinning and cardiac
contractile impairment. Therefore, relatively insufficient micro-
vessel is a key pathological feature in the transition from adaptive
cardiac hypertrophy to cardiac dysfunction.
Integrin linked kinase (ILK) is a serine/threonine protein kinase,
as a downstream kinase of b- integrin. It is an important
component of mechanical stretch sensor, which can transduce
mechanical signal to intra-cellular biomechanical signals, and
initiate a serial of cellular responses [6,7]. When cardiac pre-load
increased, ILK is thought to transduce cardiac pressure load into a
cellular compensatory growth program via activation of the Rho
family guanine triphosphatases, ras-related C3 botulinum toxin
substrate 1 (Rac1) and Cell division control protein 42 (Cdc42) [8].
ILK is also observed to promote vascular development and
angiogenesis. In ILK knockout mice and zebrafish, the vasculature
formation is markedly abnormal [9]. Vascular endothelial growth
factor (VEGF) was identified as downstream of ILK to induce
tissue angiogenesis. Several study revealed ILK was involved in
cancer cell VEGF expression and tumor angiogenesis [10].
In our pervious work, overexpression of ILK after myocardial
infarction can significantly induced myocardium hypertrophy and
tissue angiogenesis to improve heart function [11]. However the
patholo-physiological role of ILK in cardiac remodeling after MI
has not been clear. Whether impairment of ILK related signaling
pathway is the key feature for transition from adaptive cardiac
hypertrophy to cardiac dysfunction needs to be clarified. To this
aim, we assessed time-dependent ILK expression in non-ischemic
myocardium after MI. We observed ILK as well as its related pro-
angiogenic signaling down-regulated during the transition from
adaptive cardiac hypertrophy to cardiac dysfunction; while the
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24115sustained ILK expression could maintain responsible angiogenesis
in myocardium and improve heart function.
Methods
Experimental design
Animal experiments were performed following the guidelines in
the Guide for the Care and Use of Laboratory Animals published
by the US National Institutes of Health (NIH publication No. 85-
23, revised 1985) and was approved by the Ethics Review Board
for Animal Studies of Nanjing Drum Tower Hospital (DTH
ERBA 66.01/005A/2010). Adult, male Sprague-Dawley rats
(n=40) weighing 200 to 220 g were used in this study. Left
anterior descending coronary artery (LAD) ligation was performed
as described previously in detail [11]. Sham-treated animals
underwent open chest surgery without coronary artery ligation. 6
MI rats and 6 sham rats were sacrificed at day 7, 28 and 56 after
myocardial infarction (MI). Before sacrificed transthoracic echo-
cardiography and cardiac catheterization were performed to
evaluate heart function. To evaluate the therapeutic effect of
sustained ILK expression in cardiac remodeling, 19 rats
underwent MI and were enrolled in study. 4 weeks after MI, the
rats were thoracotomy again. Ad-ILK or Ad-null was injected into
remote myocardium randomly and 12 rats were survived from the
operation (6 rats per group). Two weeks after operation, we
measured heart function by ECG, and executed rats to harvest
myocardium for western blot analysis.
Echocardiography and Hemodynamic Assessment
We monitored the cardiac function using transthoracic
echocardiography and hemodynamic assessment at varying
intervals (day 7, 28 and 56 post operation).
Transthoracic echocardiography was performed using a car-
diovascular ultrasound system (Vivid 7, General Electric Co.) with
a 10-MHz linear-array transducer as described previously [11].
Briefly, after anesthesia, rats are placed on a warm blanket. We
obtained the long-axis and short-axis 2-dimensional views as well
as the M-mode tracings. The measurements of left ventricular end-
systolic dimension (LVESD) and end-diastolic dimension
(LVEDD) as well as the interventricular septal thickness in diastole
(IVSd) and LV posterior wall thickness in diastole (LVPWd) were
all obtained in the M-mode tracings at the papillary muscle level
by an observer blinded to the surgery, which were repeated for at
Table 1. Heart function after MI at different time points (n=6).
1 week 4 week 8 week
sham group MI sham group MI sham group MI
LVEDD(mm) 5.5860.32 6.5360.4
*# 5.3260.28 7.8660.28
*# 5.5460.63 9.1260.36
*
LVESD(mm) 2.8760.21 4.7960.31
*# 2.9560.12 5.7560.22
*# 2.9660.51 6.8860.38
*
IVSd(mm) 1.1960.08 1.2260.04
# 1.2160.04 1.1760.03
# 1.2660.02 1.0460.09
*
LVPWd(mm) 1.260.044 1.1460.02
# 1.2360.05 1.2260.03
# 1.1860.04 1.260.01
*
FS(%) 48.861.45 26.6160.29
* 47.6963.2 26.8661.97
* 43.9165.25 24.6262.3
*
HR(bpm) 407.13613.462 384.5621.88 432.45632.13 438.33641.89 408.81622.57 451.7643.82
MAP(mmHg) 105.4167.15 70.4764.56
* 103.6766.35 81.7568.6 113.1565.98 71.1565.27
*
dp/dtmax(mmHg/s) 3341.76158.07 1522.36116.32
* 35476213.45 2009.86152.62
*# 3091.436287.45 1195.46267.38
*
LVEDP(mmHg) 0.7360.92 8.5261.49
*# 0.3561.35 6.1761.18
*# 0.4760.74 19.3363.82
*
#P,0.05 compared by group of 8 wks post MI.
*P,0.05 compared by sham group at each time point.
doi:10.1371/journal.pone.0024115.t001
Figure 1. ILK expression in remote myocardium at different
time points. A, in western blot, ILK protein level is significantly
increased 4 weeks after MI, and return to normal 8 weeks after MI; B, in
parallel with protein level, ILK mRNA expression is significantly
increased 4 wks post MI (n=6). # P,0.05 compared by group of
8 wks post MI. * P,0.05 compared by sham group.
doi:10.1371/journal.pone.0024115.g001
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used for analysis. Percent LV fractional shortening (%FS) was
obtained as follows: FS=(LVEDD-LVESD)/LVEDD6100 (%).
After echocardiography, hemodynamic assessment was per-
formed using a polyethylene catheter (PE 50, Becton-Dickinson) as
described previously [12]. LV systolic pressure (LVSP), LV end-
diastolic pressure (LVEDP), maximum positive dp/dt (+dp/
dtmax) and heart rates (HR) were recorded continuously. All
measurements were blinded to the observer.
Histology test
After hemodynamic evaluation, hearts were arrested in diastole
by intravenous administration of 2 M KCl, rapidly excised and
washed in ice-cold saline. The hearts were incised into two parts in
longitudinal axis. Half was embedded in paraffin wax. The other
was homogenized for western blot. Paraffin-embedded sections
(from basal, mid-region, and apical blocks, 5 slices/block) were
stained with hematoxylin-eosin for morphologic examination. Von
Willebrand factor (vWF) was used to detect microvessels, The
paraffin-embedded sections (2-um slices) were incubated overnight
with the rabbit-anti-rat vWF antibody (1:400, Abcom, USA),then
exposed to the secondary antibody (Dako, Northern Ireland). The
images were analyzed by two investigators who were blinded with
respect to the identification of the groups. The results were
expressed as average numbers of capillaries per 106field [11].
Western blot procedure
Remote myocardium was subsequently homogenized with a
Dounce tissue grinder in lysis buffer consistingof: 10 mM Tris/HCl
(pH 7.2), 150 mM NaCl, 0.1%SDS, 1% (v/v) Triton X-100, 1%
sodium deoxycholate, 5 mM EDTA, 1 mM Na3VO4, 50 mM
NaF, 0.2 mM phenymethylsulfonyl fluoride and protease inhibitor
cocktail (complete EDTA-free, Roche). Protein content was
determined by BCA protein assay kit (Pierce). Proteins were
separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
and transferred to polyvinylidene fluoride membranes (Immobilon-
P, Millipore). Western blots were probed with mouse anti-human
ILK antibody (1:3000, BD Transduction Laboratories), mouse anti-
rat VEGF antibody (1:1000, Santa Cruz), mouse anti-eNOS
(1:1000, BD Transduction Laboratories), mouse anti-p-eNOS
(1:100, BD Transduction Laboratories), rabbit anti-Akt (1:2000,
Cell Signaling Technology), rabbit anti-p-Akt (1:100, Cell Signaling
Technology) or mouse anti-GAPDH (1:3000, Kangchen Bio-tech).
Peroxidase-conjugated goat anti-mouse IgG or goat anti-rabbit IgG
(1:10,000, Santa Cruz Biotechnology) was used as secondary
antibody, and bands were visualized by enhanced chemilumines-
cence (Amersham) or Chemiluminescence HRP substrate (Milli-
pore) in conjunction with BioMax films (Kodak).
Quantitative Real-Time PCR
Total RNA from remote myocardium was prepared by Trizol
(Invitrogen) using protocols provided by the manufacturer. cDNA
was produced using PrimeScript
tm RT reagent Kit (TaKaRa).
Real-time PCR was performed as described previously [13].
Transcript levels of integrin linked kinase (ILK) was determined as
the relative number of transcripts to those of glyceraldehydes-3-
phosphate dehydrogenase and normalized to the mean value of
control hearts. Primers for ILK and glyceraldehydes-3-phosphate
dehydrogenase: ILK, CAACCCTCATCACACACTGG (for-
ward), GCCATGTCCAAAGCAAACTT (reverse); ANF: CTTG-
CGGTGTGTCACACAGC (forward), GGGAGAGGTAAGG-
CCTCACT (reverse); GAPDH: AACGACCCCTTCATTGAC
(forward), TCCACGACATACTCAGCAC (reverse).
Data analysis
Descriptive statistics are expressed as group means+standard
error. All data analysis was performed by ANOVA with Dunnett’s
post-test. All data were analysed using of SPSS 16.0 statistical
software (SPSS, Inc, Chicago, IL, USA). Statistical significance
was defined as p,0.05.
Figure 2. Alternation of angiogenesis signal in remote cardiac tissue at different time points. A, Representative western blot results of
VEGF, p-eNOS and p-Akt; B, After MI, VEGF protein expression is increased until 4 wks, and decreased significantly 8 wks post MI; C, Phosphorylation
of eNOS is also significantly increased after MI. At 8 wks post MI, p-eNOS level is decreased significantly; D, Phosphorylation of AKT level is
significantly increased after MI, but not reduced at 8 weeks post MI (n=6). # P,0.05 compared by group of 8 wks post MI. * P,0.05 compared by
sham group.
doi:10.1371/journal.pone.0024115.g002
ILK in Cardiac Maladaptation
PLoS ONE | www.plosone.org 3 September 2011 | Volume 6 | Issue 9 | e24115Results
Cardiac function was significantly deteriorated 8 weeks
post-MI
In this study, we ligated left anterior descending coronary artery
to achieve experimental rat MI model. After MI, we used
echocardiograph and hemodynamic assessment to assess heart
function. We observed cardiac function was maintained until 4
weeks, and significantly deteriorated 8 weeks post-MI (Table 1). In
echocardiography (ECG) assessment, impaired cardiac function
measured as FS were observed after MI. Left ventricular end
systolic and diastolic diameters (LVEDD and LVESD) were
increased significantly and consistently during cardiac remodeling
after infarction. LV posterior wall in diastolic (LVPWd), which was
non-ischemic myocardium, were moderately thicker compared
with sham 4 weeks after MI, and markedly decreased 8 weeks after
MI. Hemodynamic assessment showed mean artery pressure, dp/
dtmax and LV end-diastolic pressure (LVEDP), but no HR, were
markedly altered after MI. The global LV systolic function, as
assessed by dp/dtmax and LVEDP was little changed until 4 weeks
after MI, while it significantly deteriorated 8 weeks post MI. These
results indicated that the shift from heart functional compensatory
to decompensatory occurred during 4 to 8 weeks post-MI.
ILK and angiogenesis related molecular expression was
reduced at 8 weeks post-MI
We observed LV mechanical stretch, measured as LVEDP, was
consistently increased during cardiac remodeling after MI. Since
ILK was a key kinase in mechanical stretch sensor, we wanted to
assess its change in myocardium during the cardiac remodeling
process. Western blot and real time PCR were used to assess ILK
expression. We observed that ILK expression in non-ischemic
myocardium was increased and went to peak around 4 weeks post-
MI, followed by a decline and eventually tapered off by 8 weeks
(Fig. 1A). Consistent with protein alternation, ILK mRNA
expression was also significantly deceased 8 weeks post MI
(Fig. 1B). This alternation of ILK expression occurred during 4
weeks to 8 weeks after MI, paralleled with onset of cardiac
function decompensatory.
Because ILK could induce VEGF expression to promote
angiogenesis [10], we further measured VEGF, p-eNOS/eNOS
and p-Akt/Akt level in myocardium. We observed VEGF and
Figure 3. Microvessel density is significantly decreased in the remote myocardium eight weeks post MI. A to D, Representative tissue
slide from remote myocardium with vWF staining in sham (A), one week (B), four weeks (C) and eight weeks group (D); E, Accumulated results show
microvessel density is significantly increased in peri-infarct zone after MI. No temporal changes of microvessel density in peri-infarct myocardium is
observed after MI. F, Accumulated results show microvessel density in remote myocardium is moderately increased after MI, and significantly
decreased eight weeks post MI (n=4). # P,0.05 compared by group of 8 wks post MI. * P,0.05 compared by sham group.
doi:10.1371/journal.pone.0024115.g003
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changed followed ILK expression up and down. As most
important endothelial cell mitogen [14], VEGF expression in the
remote myocardium went to peak 4 weeks and returned to
baseline 8 weeks post MI (Fig. 2B). Angiogenesis key kinase, eNOS
was also significantly phosphorylated until 4 weeks post MI, but
was dephosphorylated 8 weeks post MI (Fig. 2C). We further
assessed ILK downstream kinase Akt activity. Phosphorylated Akt
level was significantly increased after MI, but no significant
alternation was observed among three time points after MI
(Fig. 2D). All these results suggested angiogenesis was activated
consistently for about 4 weeks after infarction. When ILK
expression was down-regulated, angiogenesis related signaling
pathway was also weakened.
Reduced myocytes and microvessel were observed 8
weeks post MI
Angiogenesis pathway was down-regulated in non-ischemic
myocardium 8 weeks post MI. Furthermore we assessed the
microvessel density by histological analysis. von Willebrand factor
(vwF) was selected as endothelial cell biomarker in immune-
staining. In peri-infarct zone, microvascular density was signifi-
cantly increased in the MI group compared with sham group. No
difference of microvessel density was observed among three time
points after MI (Fig. 3E). In remote zone, microvessel density was
moderately increased after MI, but not reached significantly
difference compared with sham. In rats executed 8 weeks after MI,
the microvessel density was significantly decreased compared with
those in rats executed other time spots after MI (Fig. 3F).
Because microvessel was crucial for myocytes alive, whether
decreased micovessel resulted in hypertrophical myocytes loss
needed to be elucidated. Thus we observed pathological
alternation of myocytes in non-ischemic myocardium by hema-
toxylin-eosin staining. A point-to-point perpendicular line was
drawn across the cross-sectional area of the myocytes at the level of
the nucleus as previous described [15]. Significantly hypertrophy
and loss of myocytes in the remote zone (LV posterior wall) was
observed 8 weeks post MI compared with sham. Myocyte size was
significantly increased 4 weeks and 8 weeks post MI (Fig. 4E). We
also detected hypertrophy gene atrial natriuretic factor (ANF)
expression by realtime PCR. We observed ANF mRNA expression
was significantly increased after MI (Fig. 4F). While myofilament
density in remote zone, which was defined as the total number of
Figure 4. Myocytes in remote myocardium are hypertrophy
and loss after infarction. A to D, Representative tissue slide from
remote myocardium with HE in sham (A), one week (B), four weeks (C)
and eight weeks group (D); E, Accumulated results show myocytes size
significantly increases four wks and eight wks post MI; F, Accumulated
results show ANF, which is the hypertrophic factor, is up-regulated
after MI. G, Accumulated results show myofilament density is
significantly decreased eight weeks post MI (n=4). # P,0.05
compared by group of 8 wks post MI. * P,0.05 compared by sham
group.
doi:10.1371/journal.pone.0024115.g004
Table 2. Heart function after MI was perserved in Ad-ILK
treated hearts (n=6).
4 week 6 week
control ILK control ILK
LVEDD(mm) 7.2560.11 7.17660.12 8.0960.08 8.0660.11
LVESD(mm) 5.1060.05 5.0460.06 6.0560.07 5.6860.07
*
IVSd(mm) 1.1860.01 1.1860.01 1.1560.01 1.1560.01
LVPWd(mm) 1.2060.01 1.2060.01 1.1860.01 1.2760.01
FS(%) 29.6760.85 29.7461 25.2460.24 29.5161.33
*
*P,0.05 compared by sham group at each time point.
doi:10.1371/journal.pone.0024115.t002
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markedly decreased 8 weeks post MI (Fig. 4G). All these results
indicated myocyte became hypertrophy in remote myocardium
after MI. When neovasculerization dysfunction occurred 8 weeks
after MI, myocytes was dead and cell density was decreased.
ILK overexpression rescues heart failure by angiogenesis
To further verify that down-regulation of ILK accelerated
cardiac remodeling and heart dysfunction via affecting tissue
angiogenesis; we observed the therapeutic effect of sustained ILK
expression in heart failure. To the aim, Ad-ILK was injected into
remote myocardium to induce ILK expression continually 4 weeks
after MI. Ad-null was used to inject as control. Two weeks after
operation, we observed better heart function in ILK expressed rats
after MI (Table 2). Ad-ILK treated rats have significantly higher
FS level and smaller LVESD compared with those in Ad-null
treated rats. The marked difference of FS and LVESD between
Ad-ILK treated and control group indicated that ILK sustained
rather than temporarily expression could slow down heart function
deterioration after MI. Other parameters such as LVEDD and
LVPWd revealed no difference between these two groups.
After ECG, myocardium was harvest for western blot analysis.
We observed marked increased ILK expression in Ad-ILK treated
myocardium (Fig. 5B). In ILK sustained expressed myocardium,
VEGF expression (Fig. 5C) and phosphorylation of eNOS (Fig. 5D)
were also significantly increased, indicating prolonged angiogen-
esis pathway activation in ILK sustained expressed myocardium.
All of these results demonstrated once ILK expression was
recovered, the angiogenesis related molecular was up-regulated
again and heart function was preserved.
Discussion
In present study, we observed that ILK expression was
temporarily increased in non-ischemic myocardium by infarction,
and decreased from 4 to 8 weeks post MI. During this period, the
heart function of experimental MI rats was shift from compensatory
to decompensatory. Further analysis revealed that down-regulation
of ILK caused VEGF dependent angiogenesis dysfunction and
myocytes loss in remote myocardium. Sustained expression of ILK
by Ad-virus delivery could effectively promote angiogenesis and
preserve heart function.
After myocardial infarction, non-ischemic myocyte hypertrophy
is an adaptive response to increased external load, but sustained
overload eventually results in progression from adaptive hyper-
trophy to failure. In previous works, heart failure of rat is
established 6 to 9 weeks after myocardium infarction [16,17,18].
Figure 5. when ILK expression is increased by gene tranfected, angiogenesis signal pathway is activated in myocardium. A,
Representative western blot results of ILK, VEGF and p-eNOS in the myocardium from Ad-ILK treated and control groups; B, Accumulated results
show ILK expression is increased in Ad-ILK treated myocardium; C and D, VEGF and p-eNOS level is also increased in Ad-ILK treated myocardium
(n=6). P,0.05 compared by control group.
doi:10.1371/journal.pone.0024115.g005
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dtmax and LVEDP are preserved until 4 weeks post-MI, and
significantly deteriorated 8 weeks post-MI. These results indicate
heart function is compensatory until 4 weeks in our animal model,
but goes to failure 8 weeks post MI.
One important component to preserve cardiac function after
MI is neovasculerization in remote myocardium [19,20]. Insuffi-
cient microvessel adaptation in related to the degree of myocyte
hypertrophy is an important reason for cell death, leading to
progressive cardiac dysfunction in HF. In previous study, an
adenoviral vector encoding the ectodomain of fetal liver kinase
1(FLK1), which inhibits VEGF related angiogenesis, is used in
transverse aortic constriction (TAC) mice. Impaired VEGF
pathway causes that angiogenesis does not keep pace with myocyte
hypertrophy, contractile dysfunction and heart failure is acceler-
ated [4]. In adiponectin knockout mice, which angiogenesis is
interrupted, similar result is observed [21]. Other reports also
reveal that microvessel density eventually decreases when heart
failure occurs [22,23]. In our study, p-eNOS/eNOS are increased
until 4 weeks, and significantly decreased 8 weeks post-MI. In
consistent with downregulation of pro-angiogenic signaling,
histology study also shows microvessel density and myocyte
number are reduced simultaneously 8 weeks post MI. Therefore
we suggest that in the process of cardiac remodeling, impaired
ILK related angiogenesis is the key feature when heart failure
occurs.
Under LV strength stimulation, ILK is thought to promote
tissue neovasulerization by VEGF. In present study, VEGF is
observed to increase temporarily and return to normal 8 weeks
post MI. Similar VEGF expression pattern is reported by previous
work. In remote zone of experimental MI rat, VEGF level is
increased in a time dependent pattern until about 40 days post
operation [22]. These results demonstrate VEGF expression
alternated in the process of cardiac remodeling. However unlike
infarction zone, there is no ischemia in the remote myocardium.
Therefore the VEGF expression would not depend on hypoxia
related signal pathway, other mechanism would exist. The VEGF
expression in our study is in accompany with ILK. ILK is an
important protein to transduce mechanical stress to molecular
signaling events in cell. It could interact with PI3K to
phosphorylate Akt [24]. In tumor tissue, ILK is observed to
induce VEGF expression by Akt-mTOR dependent pathway [10].
In our previous work, overexpression of ILK is observed to induce
angiogenesis in heart by Akt activation [11]. Here, we observe
temporally upregulation of ILK and VEGF simultaneously after
infarction, indicating that ILK initiated VEGF expression in non-
ischemic myocardium. When the external preload prolonged, ILK
expression eventually returned to normal, and caused responsible
VEGF expression attenuation. To further verify this mechanism,
we induce ILK sustained expression 4 weeks after MI. When the
pathological down-reguation of ILK is inverted, the VEGF in
myocardium is never decreased and heart function is significantly
improved.
There are many limitations in our study. First, in our animal
model, heart function is compensatory until 4 weeks post MI by
non-ischemic myocardium hypertrophy. But no increased ven-
tricular wall thickness at 4 weeks post MI was observed. The
reason should be insufficient resolving power of rat echocardio-
gram and sample number is relative small. Second, we further
observe that ILK downstream kinase Akt is phosphrylated in non-
ischemic myocardium after MI. But p-Akt level is not changed
when ILK level is decreased. Akt could be phosphrylated by
several kinase, such as ILK, PKC, ATM kinase as well as
mTORC2 in a PI3K dependent manner [25]. Therefore,
consistent with previous report [26], Akt could be still activated
by other signaling pathway in heart failure, though ILK expression
and activity is already decreased. On the other hand, ILK induced
VEGF expression would not depend on Akt pathway in myocyte,
further work needs to elucidate this issue.
In present study, we demonstrated that ILK could induce
VEGF expression and a beneficial angiogenesis to maintain
cardiac hypertrophy. Once ILK expression was decreased, VEGF
dependent angiogenesis was attenuated, leading to myocyte death
and heart failure. Furthmore sustained ILK expression could
maintain angiogenesis in hypertropical myocardium, and preserve
heart function after MI. Therefore ILK expression alternation was
a critical pathophysiological feature that contributes to the
transition from adaptive cardiac hypertrophy to cardiac dysfunc-
tion. Understanding the ILK related mechanism of cardiac
maladaptation may lead to a new strategy for treatment of heart
failure after infarction.
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